A randomized, double-blind, placebo-controlled sequential clinical trial of sodium valproate [valproic acid] in ALS [amyotrophic lateral sclerosis]
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Valproic acid (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 31 Aug 2009 Results were published in Annals of Neurology.
- 01 May 2007 Biomarkers information updated
- 25 Aug 2006 New trial record.